Company Filing History:
Years Active: 2005
Title: Minako Akabane: Innovator in Iminoheterocyclic Compounds
Introduction
Minako Akabane is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors in the brain. Her work is crucial for advancing therapeutic options for cerebral dysfunction.
Latest Patents
Minako holds a patent for di-substituted iminoheterocyclic compounds. This patent describes compounds that exhibit a strong affinity for α4β2 nicotinic acetylcholine receptors. These compounds are designed to activate these receptors, thereby providing preventive or therapeutic effects on cerebral dysfunction. She has 1 patent to her name, showcasing her innovative approach to drug development.
Career Highlights
Minako Akabane is associated with Daiichi Suntory Pharma Co., Ltd., where she has been instrumental in research and development. Her expertise in medicinal chemistry has led to advancements in the understanding of how certain compounds can influence neurological functions.
Collaborations
Minako has collaborated with notable colleagues, including Masahiro Imoto and Tatsuya Iwanami. These partnerships have fostered a collaborative environment that enhances the research output and innovation within her team.
Conclusion
Minako Akabane's contributions to the field of medicinal chemistry are noteworthy. Her innovative work on iminoheterocyclic compounds has the potential to significantly impact therapeutic strategies for cerebral dysfunction.